These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32753233)

  • 1. Adolescent Attention-Deficit/Hyperactivity Disorder: Understanding Teenage Symptom Trajectories.
    Shaw P; Sudre G
    Biol Psychiatry; 2021 Jan; 89(2):152-161. PubMed ID: 32753233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Genetic Risk Variants With Attention-Deficit/Hyperactivity Disorder Trajectories in the General Population.
    Riglin L; Collishaw S; Thapar AK; Dalsgaard S; Langley K; Smith GD; Stergiakouli E; Maughan B; O'Donovan MC; Thapar A
    JAMA Psychiatry; 2016 Dec; 73(12):1285-1292. PubMed ID: 27806167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Persistence, Remission, and Emergence of Attention-Deficit/Hyperactivity Disorder in Young Adulthood.
    Agnew-Blais JC; Polanczyk GV; Danese A; Wertz J; Moffitt TE; Arseneault L
    JAMA Psychiatry; 2016 Jul; 73(7):713-20. PubMed ID: 27192174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and Environmental Influences on the Developmental Course of Attention-Deficit/Hyperactivity Disorder Symptoms From Childhood to Adolescence.
    Pingault JB; Viding E; Galéra C; Greven CU; Zheng Y; Plomin R; Rijsdijk F
    JAMA Psychiatry; 2015 Jul; 72(7):651-8. PubMed ID: 25945901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trajectories of cerebral cortical development in childhood and adolescence and adult attention-deficit/hyperactivity disorder.
    Shaw P; Malek M; Watson B; Greenstein D; de Rossi P; Sharp W
    Biol Psychiatry; 2013 Oct; 74(8):599-606. PubMed ID: 23726514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neural and genetic underpinnings of different developmental trajectories of Attention-Deficit/Hyperactivity Symptoms in children and adolescents.
    Wang Y; Ma L; Wang J; Ding Y; Liu N; Men W; Tan S; Gao JH; Qin S; He Y; Dong Q; Tao S
    BMC Med; 2024 Jun; 22(1):223. PubMed ID: 38831366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Childhood to Adolescent Attention Deficit/Hyperactivity Disorder Symptom Trajectories and Late Adolescent Disordered Eating.
    Yilmaz Z; Javaras KN; Baker JH; Thornton LM; Lichtenstein P; Bulik CM; Larsson H
    J Adolesc Health; 2017 Aug; 61(2):140-146. PubMed ID: 28734322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is emotional dysregulation a component of attention-deficit/hyperactivity disorder (ADHD)?].
    Villemonteix T; Purper-Ouakil D; Romo L
    Encephale; 2015 Apr; 41(2):108-14. PubMed ID: 24703785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain Signatures During Reward Anticipation Predict Persistent Attention-Deficit/Hyperactivity Disorder Symptoms.
    Chen D; Jia T; Cheng W; Cao M; Banaschewski T; Barker GJ; Bokde ALW; Bromberg U; Büchel C; Desrivières S; Flor H; Grigis A; Garavan H; Gowland PA; Heinz A; Ittermann B; Martinot JL; Paillère Martinot ML; Nees F; Orfanos DP; Paus T; Poustka L; Fröhner JH; Smolka MN; Walter H; Whelan R; Robbins TW; Sahakian BJ; Schumann G; Feng J;
    J Am Acad Child Adolesc Psychiatry; 2022 Aug; 61(8):1050-1061. PubMed ID: 34954028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and diagnosis of adult attention-deficit/hyperactivity disorder: analysis of expanded symptom criteria from the Adult ADHD Clinical Diagnostic Scale.
    Kessler RC; Green JG; Adler LA; Barkley RA; Chatterji S; Faraone SV; Finkelman M; Greenhill LL; Gruber MJ; Jewell M; Russo LJ; Sampson NA; Van Brunt DL
    Arch Gen Psychiatry; 2010 Nov; 67(11):1168-78. PubMed ID: 21041618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterotypic trajectories of dimensional psychopathology across the lifespan: the case of youth-onset attention deficit/hyperactivity disorder.
    Manfro AG; Santoro M; Polanczyk GV; Gadelha A; Pan PM; Bressan RA; Brietzke E; Talarico F; Belangero S; Rohde LA; Salum GA
    J Child Psychol Psychiatry; 2019 May; 60(5):533-544. PubMed ID: 30329156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of attention deficit hyperactivity disorder using imaging and signal processing techniques.
    Sridhar C; Bhat S; Acharya UR; Adeli H; Bairy GM
    Comput Biol Med; 2017 Sep; 88():93-99. PubMed ID: 28709145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-rater developmental trajectories of hyperactivity-impulsivity and inattention symptoms from 1.5 to 17 years: a population-based birth cohort study.
    Vergunst F; Tremblay RE; Galera C; Nagin D; Vitaro F; Boivin M; Côté SM
    Eur Child Adolesc Psychiatry; 2019 Jul; 28(7):973-983. PubMed ID: 30506420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growing out of attention deficit hyperactivity disorder: Insights from the 'remitted' brain.
    Sudre G; Mangalmurti A; Shaw P
    Neurosci Biobehav Rev; 2018 Nov; 94():198-209. PubMed ID: 30194962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the Heritability of Structural and Functional Brain Connectivity in Families Affected by Attention-Deficit/Hyperactivity Disorder.
    Sudre G; Choudhuri S; Szekely E; Bonner T; Goduni E; Sharp W; Shaw P
    JAMA Psychiatry; 2017 Jan; 74(1):76-84. PubMed ID: 27851842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.
    Nasser A; Hull JT; Chaturvedi SA; Liranso T; Odebo O; Kosheleff AR; Fry N; Cutler AJ; Rubin J; Schwabe S; Childress A
    CNS Drugs; 2022 Aug; 36(8):897-915. PubMed ID: 35896943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Childhood and Adult Persistent Attention-Deficit/Hyperactivity Disorder on Risk of Motor Vehicle Crashes: Results From the Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder.
    Roy A; Garner AA; Epstein JN; Hoza B; Nichols JQ; Molina BSG; Swanson JM; Arnold LE; Hechtman L
    J Am Acad Child Adolesc Psychiatry; 2020 Aug; 59(8):952-963. PubMed ID: 31445873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Genetic and Environmental Risks for Attention-Deficit/Hyperactivity Disorder With Hypomanic Symptoms in Youths.
    Hosang GM; Lichtenstein P; Ronald A; Lundström S; Taylor MJ
    JAMA Psychiatry; 2019 Nov; 76(11):1150-1158. PubMed ID: 31411648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal mapping of cortical thickness and clinical outcome in children and adolescents with attention-deficit/hyperactivity disorder.
    Shaw P; Lerch J; Greenstein D; Sharp W; Clasen L; Evans A; Giedd J; Castellanos FX; Rapoport J
    Arch Gen Psychiatry; 2006 May; 63(5):540-9. PubMed ID: 16651511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-behavior patterns define a dimensional biotype in medication-naïve adults with attention-deficit hyperactivity disorder.
    Lin HY; Cocchi L; Zalesky A; Lv J; Perry A; Tseng WI; Kundu P; Breakspear M; Gau SS
    Psychol Med; 2018 Oct; 48(14):2399-2408. PubMed ID: 29409566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.